Iterative Nonproteinogenic Residue Incorporation Yields α/β-Peptides with a Helix-Loop-Helix Tertiary Structure and High Affinity for VEGF

Overview

Journal Chembiochem

Specialty Biochemistry

Date 2016 Nov 30

PMID 27897370

Citations 9

Authors

James W Checco

Samuel H Gellman

Affiliations

Soon will be listed here.

Abstract

Inhibition of specific protein-protein interactions is attractive for a range of therapeutic applications, but the large and irregularly shaped contact surfaces involved in many such interactions make it challenging to design synthetic antagonists. Here, we describe the development of backbone-modified peptides containing both α- and β-amino acid residues (α/β-peptides) that target the receptor-binding surface of vascular endothelial growth factor (VEGF). Our approach is based on the Z-domain, which adopts a three-helix bundle tertiary structure. We show how a two-helix "mini-Z-domain" can be modified to contain β and other nonproteinogenic residues while retaining the target-binding epitope by using iterative unnatural residue incorporation. The resulting α/β-peptides are less susceptible to proteolysis than is their parent α-peptide, and some of these α/β-peptides match the full-length Z-domain in terms of affinity for receptor-recognition surfaces on the VEGF homodimer.

Citing Articles

Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA-peptide conjugates.

Brennecke B, Civili B, Sabale P, Barluenga S, Meyer B, Winssinger N Proc Natl Acad Sci U S A. 2025; 122(7):e2412850122.

PMID: 39951509 PMC: 11848287. DOI: 10.1073/pnas.2412850122.

Differential membrane binding of α/β-peptide foldamers: implications for cellular delivery and mitochondrial targeting.

Lee T, Checco J, Malcolm T, Eller C, Raines R, Gellman S Aust J Chem. 2023; 76(8):482-492.

PMID: 37780415 PMC: 10540276. DOI: 10.1071/ch23063.

Peptide foldamer-based inhibitors of the SARS-CoV-2 S protein-human ACE2 interaction.

Markovic V, Shaik J, Ozga K, Ciesiolkiewicz A, Lizandra Perez J, Rudzinska-Szostak E J Enzyme Inhib Med Chem. 2023; 38(1):2244693.

PMID: 37605435 PMC: 10446788. DOI: 10.1080/14756366.2023.2244693.

Unnatural helical peptidic foldamers as protein segment mimics.

Sang P, Cai J Chem Soc Rev. 2023; 52(15):4843-4877.

PMID: 37401344 PMC: 10389297. DOI: 10.1039/d2cs00395c.

Structure-Based Design of Peptides Targeting VEGF/VEGFRs.

Di Stasi R, De Rosa L, DAndrea L Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375798 PMC: 10302803. DOI: 10.3390/ph16060851.

References

Johnson L, Mortenson D, Yun H, Seth Horne W, Ketas T, Lu M . Enhancement of α-helix mimicry by an α/β-peptide foldamer via incorporation of a dense ionic side-chain array. J Am Chem Soc. 2012; 134(17):7317-20. PMC: 3377471. DOI: 10.1021/ja302428d. View

Seth Horne W, Price J, Keck J, Gellman S . Helix bundle quaternary structure from alpha/beta-peptide foldamers. J Am Chem Soc. 2007; 129(14):4178-80. DOI: 10.1021/ja070396f. View

Keskin O, Gursoy A, Ma B, Nussinov R . Principles of protein-protein interactions: what are the preferred ways for proteins to interact?. Chem Rev. 2008; 108(4):1225-44. DOI: 10.1021/cr040409x. View

Sadowsky J, Schmitt M, Lee H, Umezawa N, Wang S, Tomita Y . Chimeric (alpha/beta + alpha)-peptide ligands for the BH3-recognition cleft of Bcl-XL: critical role of the molecular scaffold in protein surface recognition. J Am Chem Soc. 2005; 127(34):11966-8. DOI: 10.1021/ja053678t. View

Haase H, Peterson-Kaufman K, Levengood S, Checco J, Murphy W, Gellman S . Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling. J Am Chem Soc. 2012; 134(18):7652-5. PMC: 3551614. DOI: 10.1021/ja302469a. View

Peterson-Kaufman K, Haase H, Boersma M, Lee E, Fairlie W, Gellman S . Residue-Based Preorganization of BH3-Derived α/β-Peptides: Modulating Affinity, Selectivity and Proteolytic Susceptibility in α-Helix Mimics. ACS Chem Biol. 2015; 10(7):1667-75. PMC: 4666709. DOI: 10.1021/acschembio.5b00109. View

Fuh G, Wu P, Liang W, Ultsch M, Lee C, Moffat B . Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab. J Biol Chem. 2005; 281(10):6625-31. DOI: 10.1074/jbc.M507783200. View

Seth Horne W, Price J, Gellman S . Interplay among side chain sequence, backbone composition, and residue rigidification in polypeptide folding and assembly. Proc Natl Acad Sci U S A. 2008; 105(27):9151-6. PMC: 2453709. DOI: 10.1073/pnas.0801135105. View

Cheloha R, Sullivan J, Wang T, Sand J, Sidney J, Sette A . Consequences of periodic α-to-β(3) residue replacement for immunological recognition of peptide epitopes. ACS Chem Biol. 2015; 10(3):844-54. PMC: 4372116. DOI: 10.1021/cb500888q. View

10.

Arkin M, Tang Y, Wells J . Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem Biol. 2014; 21(9):1102-14. PMC: 4179228. DOI: 10.1016/j.chembiol.2014.09.001. View

11.

Starovasnik M, Braisted A, Wells J . Structural mimicry of a native protein by a minimized binding domain. Proc Natl Acad Sci U S A. 1997; 94(19):10080-5. PMC: 23311. DOI: 10.1073/pnas.94.19.10080. View

12.

Seth Horne W, Johnson L, Ketas T, Klasse P, Lu M, Moore J . Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers. Proc Natl Acad Sci U S A. 2009; 106(35):14751-6. PMC: 2736470. DOI: 10.1073/pnas.0902663106. View

13.

Jones S, Thornton J . Principles of protein-protein interactions. Proc Natl Acad Sci U S A. 1996; 93(1):13-20. PMC: 40170. DOI: 10.1073/pnas.93.1.13. View

14.

Fellouse F, Wiesmann C, Sidhu S . Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci U S A. 2004; 101(34):12467-72. PMC: 515084. DOI: 10.1073/pnas.0401786101. View

15.

Wiesmann C, Fuh G, Christinger H, Eigenbrot C, Wells J, de Vos A . Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell. 1997; 91(5):695-704. DOI: 10.1016/s0092-8674(00)80456-0. View

16.

Fellouse F, Esaki K, Birtalan S, Raptis D, Cancasci V, Koide A . High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol. 2007; 373(4):924-40. DOI: 10.1016/j.jmb.2007.08.005. View

17.

Webster J, Zhang R, Gambhir S, Cheng Z, Syud F . Engineered two-helix small proteins for molecular recognition. Chembiochem. 2009; 10(8):1293-6. DOI: 10.1002/cbic.200900062. View

18.

Baum R, Prasad V, Muller D, Schuchardt C, Orlova A, Wennborg A . Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules. J Nucl Med. 2010; 51(6):892-7. DOI: 10.2967/jnumed.109.073239. View

19.

Boersma M, Haase H, Peterson-Kaufman K, Lee E, Clarke O, Colman P . Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain. J Am Chem Soc. 2011; 134(1):315-23. PMC: 3364022. DOI: 10.1021/ja207148m. View

20.

Seth Horne W, Boersma M, Windsor M, Gellman S . Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domains. Angew Chem Int Ed Engl. 2008; 47(15):2853-6. PMC: 3429126. DOI: 10.1002/anie.200705315. View